PDE4A and metabolic dysfunction-associated steatotic liver disease: This comprehensive review presents current research on PDE4 and its potential utility as a therapeutic target in GI and liver diseases, including inflammatory bowel diseases (IBDs), alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), liver fibrosis, digestive tract tumors, and possibly other conditions.